News and Trends 19 Feb 2020
Belgian Biotech Raises €50M to Make Gene Therapy Manufacturing Cheaper
An equity investment worth up to €50M will push to market Univercells’ manufacturing technology, which is designed to reduce the costs of viral vector production for gene therapies. The investment comes from Gamma Biosciences, an investment platform supported by the US investor KKR. Gamma Biosciences aims to acquire and invest in businesses developing gene and […]